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Abstract
OBJECTIVE: The objective of this selective EBM review is to determine whether or not Lowlevel laser therapy (LLLT) is an effective therapy in reducing pain and ulcer size in diabetic
patients with foot ulcers.
STUDY DESIGN: Systematic review of three randomized controlled trials (RCTs) from peer
reviewed journals, published in 2015, 2016 and 2017.
DATA SOURCES: The studies compare the effectiveness of LLLT versus conventional wound
treatment in reducing pain and ulcer size in diabetic patients with foot ulcers. All studies were
found using PubMed and CINAHL Plus.
OUTCOMES MEASURED: Pain as perceived by the patient, measured by visual analog for pain
scale or by brief pain inventory questionnaire prior to treatment and following treatment. Ulcer
size was measured by researchers in square centimeters (cm2) or square millimeters (mm2).
RESULTS: Two of the randomized control trials suggested that the use of LLLT was significant
in pain reduction of foot ulcers in diabetic foot patients. All three randomized control trials
suggested that LLLT was statistically significant in the reduction ulcer size compared to
conventional ulcer treatment.
CONCLUSIONS: All three studies showed that there was a decrease in ulcer size and two
studies showed that there was a reduction in pain when using LLLT to treat patients with diabetic
foot ulcers, proving that it is an effective treatment option. However, further studies with larger
sample sizes that examine LLLT with uniform modalities and methods of application will be
needed to reinforce the conclusion that Low-Level Laser Therapy is an effective and reliable
therapeutic option in treating diabetic patients with foot ulcers.
KEYWORDS: Low-Level Laser Therapy, Foot ulcer
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Introduction
Diabetes mellitus a condition characterized by abnormal hyperglycemia due to either a
defect in metabolism caused by a deficiency of insulin secretion, or tissue sensitivity with
resistance to insulin. It can be broken up into two categories: type I diabetes mellitus is an
autoimmune condition that is distinguished by the destruction of pancreatic beta islet cells
resulting in the absence of insulin secretion; type II diabetes mellitus is due to tissue sensitivity
and resistance to insulin, predominantly due to genetic and environmental factors. Obesity is the
most important environmental factor causing insulin resistance. 1
There are approximately 30.3 million people in the United States that have diabetes
mellitus, a majority of which have type II.1 A number of complications are associated with
Diabetes Mellitus, many of which can result in increased morbidity and mortality. Foot ulcers are
one of the most common complication found in diabetics, and it has been found that gangrene of
the foot from ulceration and peripheral vascular disease is 30 times greater in diabetic patients
compared to age matched controls.1 The pathophysiology of foot ulcers in diabetics is not
completely understood, but it is thought to be a combination of multiple factors including
neuropathy, ischemia and infections.2 In 2014, the Centers for Disease Control and Prevention
found that 7.2 million US adults were discharged from hospitals with diabetes, and of that
number 108,000 were discharged as a result of a lower-extremity amputation. This correlates to
approximately 5 per 1,000 people with diabetes.3 According to the American Diabetes
Association, the total estimated medical costs of diagnosed diabetic patients in 2017 was $327
billion, a figure which included both medical costs and a reduction in productivity.4 With the
staggering statistics of those affected by diabetes and its complications, as well as the financial
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implications, alternative treatments to diabetes and the associated sequelae has received much
interest and controversy.
Diabetic foot ulcers typically present as ulcerations or eschar that are most commonly
found on high-pressure areas or areas exposed to repetitive stress, often at the metatarsal heads.
The cause of foot ulcers is thought to be attributed to a combination or peripheral neuropathy,
poor blood circulation and increased susceptibility to infections. Foot ulcers can go unnoticed
and grow very large due to the neuropathy and poor wound healing connected with diabetes,
which can lead to infections and ultimately gangrene and amputations if not caught early.
Conventional methods of treating diabetic foot ulcers are based on standard wound treatment
including debridement, slough excision, saline solution irrigation and betadine solution dressings
coupled with effective blood glucose control. Systemic antibiotics have also been used based on
culture and sensitivities in the presence of co-existing infections. Other treatment options
include contact case immobilization or in the incidence of gangrene or severe ulceration,
amputation has been indicated.
Low-Level Laser Therapy (LLLT) is a new alternative approach to treating diabetic foot
ulcers that is still being investigated for the efficacy of its use. Although the mechanism of action
for the Low-Level Laser is not completely understood, it is believed that the non-thermal laser
stimulates photoreceptors at a cellular level to increase the production of adenosine triphosphate
(ATP) from mitochondria, resulting in increased cellular oxygen utilization, anti-inflammatory
effects and increased blood circulation to the area.5 The utilization of Low-Level Laser Therapy
(LLLT) is still being researched in many different medical conditions to further understand its
efficacy.
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Objective
The objective of this selective evidence-based medicine review is to determine whether
Low-Level Laser Therapy (LLLT) is an effective therapy in reducing pain and ulcer size in
diabetic patients with foot ulcers.
Methods
The studies selected for this systematic review included three randomized control trials
(RCTs)that investigated the use of LLLT in diabetic adults with foot ulcers or ulcers on the distal
third of the lower leg. All three of the articles included were published in peer reviewed journals
and found using the following databases: PubMed and CINAHL Plus. The keywords used to
search relevant articles were chosen using the keywords “Low-Level Laser Therapy” and “foot
ulcers.” The articles were selected based on their relevance to one another, the clinical question
and if patient-oriented evidence that matters (POEMs) were incorporated. Articles were excluded
if they were published greater than ten years ago or were not randomized control trials.
Significance of the results was determined through evaluation of the calculated p-value, mean
change from baseline, as well as number needed to treat (NNT). Safety precautions for each of
the studies included proper eyewear for patients and researchers during the application of the
Low-Level Laser Therapy. Additional inclusion and exclusion criteria can be found in Table 1,
as well as specific demographics for each of the individual studies.
The studies were selected based on their population, intervention used and comparison
between articles. In all three of the studies the Low-Level Laser treatment was administered by
researchers, with two studies using the following laser modalities: continuous wave, visible
beam, 658 nm, 30 mW power for 80 seconds; the other study used a handheld diode laser (660
nm) for 60 seconds.2,6,7
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Table 1 – Demographics & Characteristics of Included Studies
Study

Type #
Age
Pts (years)
Carvalho, RCT 32 40-70
(2016)
years
(6)

Fietosa,
(2015)
(7)

RCT

16

N/A*

Mathur,
(2017)
(2)

RCT

30

20-75
Control
avg: 49
yrs
Treatment
avg: 54
yrs

*N/A – Not Reported in study.

Inclusion
Criteria
Type II
Diabetes
Mellitus pts
with fasting
blood
glucose
values
between
150-350
mg/dL with
an ulcer on
the foot or
on medial
or distal
third of the
leg
measuring
between 1 5 cm.
Noncontrolled
Type II
Diabetic
patients
with ulcers
on the
lower limb

Exclusion
Criteria
Fasting
blood
glucose
values
greater
than 350
mg/dL and
ulcers
greater
than 5 cm
in length

W/D

Interventions

0

LLLT via a handheld
30 mW power Laser
delivering a fluence
of ~4J/cm2 VS. daily
ulcer cleaning and
dressing application
by the patient

N/A*

N/A* LLLT via a handheld
30 mW power Laser
delivering a fluence
of ~4J/cm2 held
approximately 1 mm
perpendicular to the
wound VS. daily
Saline Solution 0.9%
irrigation

Type II
Diabetes
Mellitus
patients
with
MeggittWagner
grade I
DFUs of at
least 6week
duration

Patients
with
clinical
signs of
ischemia,
fasting
blood
sugar
levels
>200
mg/dL and
signs of
septicemia

0

LLLT via a handheld
diode laser held 1 ft
above ulcer surface
delivering a fluence
of ~3J/cm2 VS. daily
wet saline or
betadine dressings,
antibiotic treatment,
contact cast
immobilization and
slough excision

4
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In two of the studies, the control group received daily cleansing and dressings for ulcers, while
Carvalho et al. instructed its participants to perform self-cleansing on a daily basis.2,6,7 Two of
the RCTs used measured clinical outcomes in patients following 30 days of treatment, while the
Mathur et al. measured clinical outcomes after 2 weeks of treatment. 2,6,7 Ulcer size and pain
assessments were analyzed before and after the treatment to be used in comparison between the
control and experimental groups.
Outcomes measured
The primary outcome measured in all three studies was the change from baseline in ulcer
size measured by researchers, and in Feitosa et al. and Carvalho et al. pain as perceived by the
patient was a secondary measured outcome. Feitosa et al. used a Visual Analog Scale for Pain to
numerically scale the patients perceived pain, with zero indicating the absence of pain and ten
indicating maximum pain.7 Carvalho et al. used the Brief Pain Inventory and the Visual Analog
Scale for Pain to assess pain, with reported pain on a scale of zero to ten, ten being maximum
amount of pain and zero indicating the absence of pain.6 Ulcer size was measured in size square
centimeters (cm2)6 ,7 and square millimeters (mm2)2. In all three of the RCTs, Image J Software
was the measurement tool utilized. This tool uses the circumscription of the ulcer area to
measure in square centimeters or square millimeters. 2,6,7
Results
In the study conducted by Carvalho et al. 32 participants were selected based on their
demographics and meeting certain inclusion criteria. The eligibility of participants was based
upon the criteria as follows: Type II Diabetes Mellitus patients between 40-70 years old with
fasting blood glucose levels between 150-350 mg/dL with an ulcer on the foot or in the medial or
distal third of the leg, measuring between 1 and 5 cm in length. 6 Of the 32 eligible participants,
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all 32 completed the 30-day program. Initially, each individual was evaluated by an angiologist
to evaluate the ulcer clinically, as well as Doppler ultrasound and ankle-brachial index (ABI).
The purpose of the use of the Doppler ultrasound and ABI was to assess the peripheral
vascularization of each individual patient.6 The participants were randomly distributed into four
different groups: the control group, Low-Level Laser Therapy group (LLLT), Essential Fatty
Acids (EFA) and LLLT with EFA (LEFA) group. The control group was instructed to clean
ulcers and apply dressings on a daily basis without assistance from researchers. Each participant
of the LLLT group received 12 treatments of phototherapy, each for 80 seconds following an
initial cleanse of the ulcer with 0.9% saline solution. Assessments were made before and after
30 days to compare results.
Following 30 days of treatment, there was a reduction in total ulcer area for the LLLT
group ( - 5.59 cm2) compared to the control group, which showed a significant increase in total
ulcer area (+ 5.88 cm2).6 The findings were statistically significant with a 95% confidence
interval (CI) and p-value of 0.00428.6 There was also a significant decrease in pain for the LLLT
group (- 4.20) compared to the control group, which had an increase in pain (+ 0.40) compared to
initial evaluation.6 The results suggest that the use of LLLT showed statistically significant
decreases in pain and total ulcer area compared to daily cleansing and dressing application. The
study by Carvalho et al. also included results of the use of Calendula officinalis alone compared
to Calendula officinalis along with LLLT, however those results are not included in this
systematic review.
In the study conducted by Feitosa et al. 16 Type II diabetic patients were randomly
selected to participate in the trial. Participants were included in the study based on their
classification of a non-controlled type II diabetic patient with an ulcer on the lower limb. The
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patient age demographics, exclusion criteria and if any patients withdrew was not reported in the
study. The 16 participants were randomly divided into two groups of eight, one group designated
as the control group and the other receiving the Low-Level Laser Therapy (LLLT). The control
group was instructed to strictly use 0.9% saline solution for daily cleansing of ulcers. The LLLT
group received daily cleansing with 0.9% saline solution irrigation followed by 80 seconds of
laser treatment administered by a researcher. There were 12 treatment procedures administered
to the LLLT group, three weekly procedures performed on alternating days. Participants from
both the control and LLLT group were evaluated by researchers for ulcer size (cm2) and pain
perceived by the patient based on the Visual Analog Scale for Pain. Participants were evaluated
on day one as well as 30 days after their respective treatment of the ulcers.
Following 30 days of treatment, there was a statistically significant reduction in ulcer size
as well as pain reduction with a p-value of <0.05.7 The LLLT group showed a reduction in ulcer
size of -5.59 cm2, while the control group showed an increase in ulcer size of +5.88 cm2.7 Using
the zero to ten scale for pain the study showed a significant reduction in pain with the LLLT
group showing -4.2 points while the control group showed a slight increase of 0.40 points. The
increase in ulcer size by the control group indicates a worsening in patients’ health, as evidenced
by the example of one participant progressing to a transfemoral amputation following the
conclusion of the study. The results of the study imply that LLLT is effective in reducing pain
and total ulcer size compared to irrigation with saline solution.
Mathur et al. gathered 30 participants between the ages of 20 and 75 years old to
participate in the study. The participants were included based on the diagnosis of Type II
Diabetes Mellitus with a Meggitt-Wagner grade 1 foot ulcer present for greater than 6 weeks
duration. Patients were excluded if there were clinical signs of ischemia, fasting blood sugar
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levels >200 mg/dL, or signs of septicemia. The participants were randomly divided into a control
group and a Low-Level Laser Therapy (LLLT) group. All participants in the study were
evaluated on days 0, 7 and 15, with no participants excluded or withdrawn from the study.
Patients in the control group received conventional wound treatment including daily wet saline
or betadine dressing, slough excision, antibiotic treatment and contact cast immobilization as
needed. The LLLT group received 60 seconds of laser exposure conducted by the researcher
every day for 15 days, as well as after each treatment moist dressing was placed over the ulcer. If
necessary as determined by the researcher, slough excision was provided to patients prior to the
exposure to the laser treatment.
At the start of the study, the average ulcer size for the control group and the treatment
group was measured and then subsequently measured on day 7 and 15. In this systematic review,
the mean change from baseline was measured using the average ulcer size on day 0 and day 15.
For the control group, the results yielded a decrease in ulcer size of 206 mm2, while the LLLT
group showed a decrease from baseline in size of 554 mm2. This indicates a statistically
significant reduction in wound size with a p-value of <0.001.2 In the LLLT group approximately
75% of patients had a wound reduction of 30-50%, compared to the control group in which
approximately 20% of patients had a wound reduction of >20%. With the provided data, the
relative benefit increase (RBI) was calculated to be 2.75, the absolute benefit increase (ABI) was
0.55 and the number needed to treat (NNT) was found to be 1.81, rounded up to 2. This data
suggests that for every 2 people with diabetic foot ulcers treated with Low-Level Laser Therapy,
one more will see a statistically significant reduction in ulcer size when compared to
conventional wound treatment.
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Table 2 – Analysis of treatment efficacy and statistical significance2
Study
Mathur
(2017)

CER
20% (0.20)

EER
75% (0.75)

RBI
275%
(2.75)

ABI
55%

NNT
2

p-value
<0.001

All three studies monitored treatment modalities for adverse events as well as provided
appropriate safety precautions to participants and researchers. No adverse events were found
from the use of the Low-Level Laser Therapy. All three of the studies found statistically
significant decreases in ulcer size as indicated by Table 2.
Table 3 – Change in ulcer size from baseline and statistical significance
Study
Carvalho (2016)6
Mathur (2017)2
Fietosa (2015)7

Change in Ulcer size
following LLLT
- 5.59 cm2
- 5.54 cm2 (554 mm2)
- 5.59 cm2

p-value
0.00428
<0.001
<0.05

Discussion
Diabetic foot ulcers have long been a significant cause of morbidity and mortality as well
as a financial burden placed on those affected. Traditional treatment options for diabetic foot
ulcers have been stalled by the associated poor neuropathy, poor wound healing and vascular
compromise that is linked to diabetes. This three-study systematic review evaluated the efficacy
of Low-Level Laser therapy as an adjunct therapy to traditional ulcer treatment resulting in
decreased pain and improved healing. As discussed previously, the mechanism of action of LowLevel Laser Therapy is not completely understood, but it is believed to be related to the laser’s
stimulation of the photoreceptors in cells which in turn activate the mitochondria to produce
adenosine triphosphate (ATP) which increases the cellular oxygen utilization. With increasing
oxygen utilization, the blood flow to the area is amplified resulting in improvements to the
healing process of the wound.5 Low-Level Laser Therapy is currently not an approved treatment
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option for diabetic foot ulcers by the FDA, as there are still clinical trials evaluating its
effectiveness. Current approved treatment options include standard wound treatment with
debridement, irrigation and dressings, as well as other options including off-loading with
contact-cast, hyperbaric oxygen therapy, and negative-pressure wound therapy.2,8 There were no
adverse results from the application of laser treatment, however appropriate safety measures
were taken with both researchers and participants wearing protective glasses during treatments.
In review of the three-systematic review studies included in this study, Low-Level Laser Therapy
has proven to be a viable, safe and effective adjunct treatment option for diabetic foot ulcers.
It is important to note the limitations to the three RCTs evaluated in this selective EBM
review. One of the biggest limitations associated with the studies conducted by Mathur et al.,
Carvalho et al. and Fietosa et al. was the small sample size assessed which was 32, 16 and 30
respectively.2,6,7 With larger sample sizes, the validity of the results found could be further
strengthened, improving the significance of the findings. A limitation to the results from
Carvalho et al. is the control group was instructed to clean ulcers and apply dressings without
assistance of researchers, which could skew results due to the potential inconsistent wound
treatment between members of the control group.6 Another limitation that is important to note is
the absence of reporting of blood glucose control in the participants of each of the studies.
Uncontrolled blood glucose levels could potentially lead to an increase in complications and
further potentiate the poor wound healing associated with diabetes. Uniform modalities and
methods of application would be needed in future studies to completely address the most
appropriate usage of laser treatment and to establish the most beneficial options for patients.

Elmer, Low-Level Laser Therapy and Diabetic Foot Ulcers 11
Despite the limitations addressed, all three RCTs were POEMs and relevant to improving
the quality of life of the population addressed. The studies were also valid as evidenced by the
presence of p-values, confidence intervals and randomization of the studies.
Conclusion
The primary objective of this systematic review was to determine whether Low-Level
Laser Therapy (LLLT) was effective in reducing pain and ulcer size in diabetic patients with foot
ulcers. After evaluation of the results presented, it is indicated that there was statistically
significant reduction in pain and ulcer size in patients treated with Low-Level Laser Therapy.
This conclusively suggests LLLT to be effective in reducing pain and ulcer size in diabetic
patients with foot ulcers. It is important to note that the use of LLLT is used in adjunct to
traditional wound treatment, and the use of LLLT as monotherapy was not addressed.
Although the popularity of LLLT has continuously increased, it is important to continue
further research to promote the efficacy of its use. In order to improve future trials, larger
sample sizes could increase the validity of the findings and improve statistical significance.
Additionally, specific blood glucose parameters could improve the consistency of findings. With
improvements in future studies and progressions in clinical research, the outlook of treating
diabetic foot ulcers could be drastically improved with the application of Low-Level Laser
Therapy, improving the quality of life and decreasing morbidity and mortality for patients
affected by diabetic foot ulcers.
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